Skip to content
ANAVEX
ANAVEX
  • HOME
  • ABOUT US
  • NEWS
  • PIPELINE
  • INVESTORS
    • Events
    • Share Data
    • Analyst Coverage
    • Code of Conduct
    • Investor Material
    • Presentations
  • JOIN US
Search
  • HOME
  • ABOUT US
  • NEWS
  • PIPELINE
  • INVESTORS
    • Events
    • Share Data
    • Analyst Coverage
    • Code of Conduct
    • Investor Material
    • Presentations
  • JOIN US

Anavex Comments on FDA Plan to Expedite Approval of New Alzheimer’s Drugs

News ReleasesBy alessandroMarch 18, 2013Leave a comment

Vancouver, BC — March 18, 2013 — Anavex Life Sciences Corp. (“Anavex”) (OTCQB: AVXL) today commented on the United States Food and Drug Administration’s (FDA) plan to expedite the approval of new treatments for Alzheimer’s disease.  As reported by the New York Times, drugs in clinical trials would qualify for approval if people with very…

ANAVEX® is a trademark of Anavex®Life Sciences Corp. - 2019 All Rights Reserved

Go to Top